G-ZRLQ6BTKDY

For Early Stage Life Sciences CEO's

Where Life Sciences CEOs
Become Investable

A sprint-based execution platform where Life Sciences CEOs build leadership, execution discipline, and investor readiness through applied progress — not pitch decks.

The Reality:
Great Science Just
Isn’t Enough

Most life science startups stall before institutional investment — not because the science fails, but because execution, leadership, and capital readiness
fall short under scrutiny.

CEOs often navigate fundraising, regulation, commercialization, and manufacturing challenges alone.

CEO360 is here to change that.

What’s Makes CEO360 Different?

Not an Accelerator.
Instead, CEO360 Builds
Investable CEOs

How CEO360 Differs From Traditional Startup Programs

Typical Startup Programs CEO360
Focus on launching companies
Focus on making CEOs and companies investable
Short-term acceleration programs
12-month execution journey
Demo day focused
Quarterly investor progress reviews
Capital fuels experimentation
Capital tied to disciplined value creation
Founder hustle and iteration
Leadership maturity and execution discipline
Broad industry focus
Specialized in life sciences, small molecule, large molecule, medtech, and tools
Pitch coaching emphasis
Company readiness and risk reduction emphasis
One-time investor exposure
Investors build conviction over time
Fast growth expectations
Sustainable investability and scale readiness

CEOs move through structured execution sprints focused on what investors
actually evaluate:

  • Leadership & governance maturity
  • Technical and regulatory readiness
  • Defensibility and risk clarity
  • Capital and commercialization discipline
  • Execution replaces theory.

How It Works:
12-Month Execution Journey

CEOs join modality-specific cohorts and progress
through four execution sprints. Each sprint ends with investor
progress sessions. Not demo days. Progress reviews.

CEO360 Peer-to-Peer Life Sciences Cohorts

From Isolation
To Collaboration

CEOs collaborate with peers facing similar technical and market realities.

It can be lonely being a CEO.

After working with over 140 CEOs, we find that CEO360 alumni stay connected, serve on each other’s scientific advisory boards, attend our ecosystem events, help mentor future CEOs and remain plugged in.

All because of the power of peer-to-peer advisory.

CEO360 2026 San Diego Life Sciences Cohorts

Small Molecule

Categories Served

  • Oncology therapeutics
  • CNS and neurological treatments
  • Rare disease therapeutics
  • Immunology & inflammation
  • Metabolic and endocrine therapies
  • Infectious disease treatments
  • Targeted small molecule platforms
  • AI-enabled drug discovery
  • Single assets or therapeutic pipelines
  • More
Large Molecule

Categories Served

  • Monoclonal antibody therapeutics
  • Bispecific and multi-specific antibodies
  • Protein and peptide therapeutics
  • Cell and gene therapy platforms
  • Engineered biologics platforms
  • Immunotherapy technologies
  • Biologics platform technologies
  • More
MedTech / Tools

Medical Devices

  • Implantable therapeutic devices
  • Wearable monitoring technologies
  • Connected care platforms
  • Surgical and interventional devices

Diagnostics

  • Molecular diagnostic platforms
  • Imaging and detection technologies
  • Point-of-care diagnostic systems

Research & Clinical Tools

  • Laboratory automation systems
  • Drug discovery instrumentation
  • Clinical workflow technologies
  • Data and analysis platforms 
  • More

Investors Refer CEOs and Return Quarterly

The CEO360
VC Investor Model

Investors now have a way to help CEOs that are close, but not quite ready for an investment.

After spending time with CEOs, VCs often identify areas that need to be strengthened prior to funding. In fact, 60% of the time VCs pass during the due diligence process.

CEO360 works closely with VC investors to address and derisk these areas, creating a win for the VC and the CEO.

VCs refer CEOs, then return every 90 days to observe execution progress.

Conviction builds through visible improvement, not polished storytelling.

Investors see progress.

CEOs have clear direction and focus.

Investability increases.

A win-win scenario.

Why CEO360? It's About Our Culture.

Serious Work.
Human Environment.

CEO360 is a confidential, peer-driven environment where CEOs can be honest, learn, and solve real problems together.

No selling.

No competition in the room.

Just operators helping fellow operators succeed.

We make it fun.

No ego contests.

We swear a lot.

There’s a “no jerk” policy. If you’re a jerk, you’re out.

No pretending.

We hold each other accountable.

We believe in each other.

And with the amazing, innovative science,
our CEOs might just save the world.

From Founder To Investable CEO.

Apply to join a CEO360 cohort
or refer a CEO who’s ready for the next stage.